Multicenter phase 3 trial comparing NeoADjuvant Ipilimumab + Nivolumab versus standard Adjuvant nivolumab in macroscopic stage III melanoma - NADINA (NCT04949113)
NADINA
This trial is No longer recruiting
Registration number NCT04949113
Program & service
This trial is being run with the Cancer service, and as part of the Medical Oncology program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Dr Miles Andrews
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR